Brazil Threatens To Break Patent On Abbott's Kaletra
Brazil has vowed to break the patent on U.S. drug maker Abbott Laboratories' HIV drug Kaletra in an effort to cut treatment costs....To view the full article, register now.
Already a subscriber? Click here to view full article